Yarbrough Capital, LLC Sarepta Therapeutics, Inc. Transaction History
Yarbrough Capital, LLC
- $2.4 Billion
- Q2 2024
A detailed history of Yarbrough Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 2,790 shares of SRPT stock, worth $347,773. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,790
Previous 2,790
-0.0%
Holding current value
$347,773
Previous $361,000
21.88%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.13 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$539 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$516 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$476 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...